ID: ALA5187119

Max Phase: Preclinical

Molecular Formula: C9H12N4O2

Molecular Weight: 208.22

Representations

Canonical SMILES:  CC(=O)n1nc2c(c1N)CC(C)C(=O)N2

Standard InChI:  InChI=1S/C9H12N4O2/c1-4-3-6-7(10)13(5(2)14)12-8(6)11-9(4)15/h4H,3,10H2,1-2H3,(H,11,12,15)

Standard InChI Key:  XESABZGPUVPKGS-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 208.22

Molecular Weight (Monoisotopic): 208.0960

AlogP: 0.26

#Rotatable Bonds: 0

Polar Surface Area: 90.01

Molecular Species: NEUTRAL

HBA: 5

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 6

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 11.13

CX Basic pKa:

CX LogP: 0.19

CX LogD: 0.19

Aromatic Rings: 1

Heavy Atoms: 15

QED Weighted: 0.64

Np Likeness Score: -0.22

References

1. Bou-Petit E, Hümmer S, Alarcon H, Slobodnyuk K, Cano-Galietero M, Fuentes P, Guijarro PJ, Muñoz MJ, Suarez-Cabrera L, Santamaria A, Estrada-Tejedor R, Borrell JI, Ramón Y Cajal S..  (2022)  Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor.,  65  (8.0): [PMID:35417652] [10.1021/acs.jmedchem.1c01941]

Source

Source(1):

• Scientific Literature